Literature DB >> 11157367

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.

F K Port1, R A Wolfe, T E Hulbert-Shearon, J T Daugirdas, L Y Agodoa, C Jones, S M Orzol, P J Held.   

Abstract

Hemodialyzer reuse is commonly practiced in the United States. Recent studies have raised concerns about the mortality risk associated with certain reuse practices. We evaluated adjusted mortality risk during 1- to 2-year follow-up in a representative sample of 12,791 chronic hemodialysis patients treated in 1,394 dialysis facilities from 1994 through 1995. Medical record abstraction provided data on reuse practice, use of bleach, dialyzer membrane, dialysis dose, and patient characteristics and comorbidity. Mortality risk was analyzed by bootstrapped Cox models by (1) no reuse versus reuse, (2) reuse agent, and (3) dialyzer membrane with and without the use of bleach, while considering dialysis and patient factors. The relative risk (RR) for mortality did not differ for patients in reuse versus no-reuse units (RR = 0.96; 95% confidence interval [CI], 0.86 to 1.08; P > 0.50), and similar results were found with different levels of adjustment and subgroups (RR = 1.01 to 1.05; 95% CI, lower bound > 0.90, upper bound < 1.19 each; each P > 0.40). The RR for peracetic acid mixture versus formalin varied significantly by membrane type and use of bleach during reprocessing, achieving borderline significance for synthetic membranes. Among synthetic membranes, mortality was greater with low-flux than high-flux membranes (RR = 1.24; 95% CI, 1.02 to 1.52; P = 0.04) and without than with bleach during reprocessing (RR = 1.24; 95% CI, 1.01 to 1.48; P = 0.04). Among all membranes, mortality was lowest for patients treated with high-flux synthetic membranes (RR = 0.82; 95% CI, 0.72 to 0.93; P = 0.002). Although mortality was not greater in reuse than no-reuse units overall, differences may exist in mortality risk by reuse agent. Use of high-flux synthetic membrane dialyzers was associated with lower mortality risk, particularly when exposed to bleach. Clearance of larger molecules may have a role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157367     DOI: 10.1053/ajkd.2001.21290

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

Review 1.  Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines.

Authors:  Satoru Kuriyama
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

Review 2.  Evidence-based cardiology in hemodialysis patients.

Authors:  Michael Allon
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

3.  Dialyzer reuse with peracetic acid does not impact patient mortality.

Authors:  T Christopher Bond; Allen R Nissenson; Mahesh Krishnan; Steven M Wilson; Tracy Mayne
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

4.  Multidisciplinary evaluation for severity of hazards applied to hemodialysis devices: an original risk analysis method.

Authors:  Carlo Alberto Lodi; Alessandro Vasta; Maria Alquist Hegbrant; Juan P Bosch; Francesco Paolini; Francesco Garzotto; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

Review 5.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

6.  The impact of membrane permeability and dialysate purity on cardiovascular outcomes.

Authors:  Gulay Asci; Huseyin Tz; Mehmet Ozkahya; Soner Duman; Meltem Sezis Demirci; Mustafa Cirit; Savas Sipahi; Hamad Dheir; Devrim Bozkurt; Fatih Kircelli; Ebru Sevinc Ok; Sinan Erten; Muhittin Ertilav; Timur Kose; Ali Basci; Jochen G Raimann; Nathan W Levin; Ercan Ok
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

Review 7.  Water quality in conventional and home haemodialysis.

Authors:  Matthew J Damasiewicz; Kevan R Polkinghorne; Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

8.  Effect of membrane permeability on survival of hemodialysis patients.

Authors:  Francesco Locatelli; Alejandro Martin-Malo; Thierry Hannedouche; Alfredo Loureiro; Menelaos Papadimitriou; Volker Wizemann; Stefan H Jacobson; Stanislaw Czekalski; Claudio Ronco; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

Review 9.  Does hemodialyzer reuse have a place in current ESRD care: "to be or not to be?".

Authors:  Gerald B Denny; Thomas A Golper
Journal:  Semin Dial       Date:  2014-03-21       Impact factor: 3.455

Review 10.  What is new in uremic toxicity?

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.